Paradigm

Paradigm was founded with the mission to revolutionize the clinical research ecosystem by creating a platform that ensures equitable access to clinical trials for all patients. The company's vision focuses on improving trial efficiency and reducing barriers for healthcare providers, thereby facilitating broader participation in clinical research. Paradigm offers a comprehensive clinical research platform designed to streamline the trial process, making it more accessible and efficient for both patients and providers.

Notable affiliates of Paradigm include industry leaders such as Kent Thoelke, Jonathan Hirsch, and Jay Trepanier, along with investors like Robert Nelsen and Hemant Taneja. The company has achieved significant milestones in enhancing patient access to clinical trials and improving the overall efficiency of the clinical research process. Paradigm's impact is evident in its contribution to making clinical trials more inclusive and efficient, thereby advancing medical research and patient care.